MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Breast Cancer Treatment Studies
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,781 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,781 works in the cohort · of 4,299,418page 22 of 56

Labels cover 13 of 2,781 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,781 of 2,781 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Staging Reclassification Affects Breast Cancer Survival
Ivo A. Olivotto, Pauline T. Truong, Caroline Speers
2003· letter· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
14
citations
affaboutunlabeled
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction
Mark Basik, Reena S. Cecchini, Jennifer De Los Santos, Heidi Umphrey, Thomas B. Julian, Eleftherios P. Mamounas +16 more
2025· letter· en· JAMA Surgery· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
14
citations
afffundno abstractunlabeled
Breast cancer recurrence following radioguided seed localization and standard wire localization of nonpalpable invasive and in situ breast cancers: 5-Year follow-up from a randomized controlled trial
Filgen Fung, Sylvie D. Cornacchi, Michael Reedijk, Nicole Hodgson, Charlie H. Goldsmith, David R. McCready +3 more
2016· article· en· The American Journal of Surgery· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
14
citations
affvenueunlabeled
Are Two-Centimeter Breast Cancers Large or Small?
Steven A. Narod, Javaid Iqbal, Anna Jakubowska, Tomasz Huzarski, Peng Sun, Cezary Cybulski +3 more
2013· article· en· Current Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
13
citations
affno abstractunlabeled
A New Radiocolloid for Sentinel Node Detection in Breast Cancer
Nicole Hodgson, Pamela Zabel, A G Mattar, C. Jay Engel, David Girvan, R. L. Holliday
2001· article· en· Annals of Surgical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
13
citations
affgemma · no categorygpt · no categorymodels agree
Identifying clinically relevant prognostic subgroups in node-positive postmenopausal HR+ early breast cancer patients treated with endocrine therapy: A combined analysis of 2,485 patients from ABCSG-8 and ATAC using the PAM50 risk of recurrence (ROR) score and intrinsic subtype.
Michael Gnant, Mitch Dowsett, Martin Filipits, Elena López‐Knowles, Richard Greil, Marija Balić +6 more
2013· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
13
citations
affno abstractgemma · no categorygpt · no categorymodels agree
Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial
Mehra Golshan, Stephanie M. Wong, Sibylle Loibl, Jens Huober, Joyce O’Shaughnessy, Hope S. Rugo +9 more
2019· article· en· European Journal of Surgical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
13
citations
affvenueunlabeled
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
Ezra Hahn, Danielle Rodin, Rinku Sutradhar, Sharon Nofech‐Mozes, Sabina Trebinjac, Lawrence Paszat +1 more
2023· review· en· Current Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
13
citations
affno abstractunlabeled
Tumour characteristics among women with very low-risk breast cancer
Steven A. Narod, Adriana Valentini, Sharon Nofech‐Mozes, Peng Sun, Wedad Hanna
2012· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
13
citations

How this was built: Screen · Findings · About